Severe corticoidrefractory thrombocytopenia, associated with mixed connective tissue disease (Sharps syndrome), treated with rituximab;schwere corticoidrefraktäre autoimmunthrombozytopenie bei sharp-syndrom therapie mit rituximab

Deutsche Medizinische Wochenschrift

Volumn 134, Issue 36, 2009, Pages 1734-1738

  Rudolph, S E ^a   Kouba, M ^a   Hrdlicka, P ^a  

^a Department of Urology   (Germany)

Author keywords

Immune thrombozytopenia; Mixed connective tissue nl disease; Rituximab; Sharps syndrome

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; AZATHIOPRINE; BILIRUBIN; CIPROFLOXACIN; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; CREATININE; ELECTROLYTE; FIBRINOGEN; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HEMOGLOBIN; PREDNISOLONE; RHEUMATOID FACTOR; RITUXIMAB; THYROTROPIN; TRIACYLGLYCEROL LIPASE; GLUCOCORTICOID; IMMUNOLOGIC FACTOR; MONOCLONAL ANTIBODY;

ABDOMEN; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BILIRUBIN BLOOD LEVEL; BLOOD PRESSURE; BODY WEIGHT; BONE MARROW BIOPSY; CASE REPORT; CLINICAL EXAMINATION; COMPLEMENT BLOOD LEVEL; CORTICOSTEROID THERAPY; CREATININE BLOOD LEVEL; DISEASE COURSE; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRY EYE; ECHOGRAPHY; ELECTROLYTE BLOOD LEVEL; ENTEROCOCCUS FAECALIS; ERYTHROCYTE COUNT; ERYTHROPOIESIS; FEMALE; FIBRINOGEN BLOOD LEVEL; FINGER; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GOOD GENERAL CONDITION; GRANULOCYTE; HEART RATE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOSUPPRESSIVE TREATMENT; LEUKOCYTE COUNT; LUNG AUSCULTATION; LYMPHADENOPATHY; MEGAKARYOCYTE; MIXED CONNECTIVE TISSUE DISEASE; NEUROLOGIC EXAMINATION; PAIN; PALPATION; PERIPHERAL EDEMA; PROTHROMBIN TIME; RAYNAUD PHENOMENON; REFRACTORY THROMBOCYTOPENIA; SEVERE CORTICOIDREFRACTORY THROMBOCYTOPENIA; SYNOVITIS; THROMBOCYTE COUNT; THYROTROPIN BLOOD LEVEL; TRIACYLGLYCEROL LIPASE BLOOD LEVEL; XEROSTOMIA; ADOLESCENT; B LYMPHOCYTE; DRUG EFFECT; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOLOGY; SPLENECTOMY; TREATMENT FAILURE; TREATMENT REFUSAL;

ADOLESCENT; ANTIBODIES, MONOCLONAL; B-LYMPHOCYTES; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOLOGIC FACTORS; MIXED CONNECTIVE TISSUE DISEASE; PREDNISOLONE; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; SPLENECTOMY; TREATMENT FAILURE; TREATMENT REFUSAL;

EID: 70149102624     PISSN: 00120472     EISSN: 14394413     Source Type: Journal    
DOI: 10.1055/s-0029-1234008     Document Type: Article

References (19)

1. Alarcón-Segovia D, Villareal M. Classification and diagnostic criteria for mixed connective tissue disease. In: Kasukawa R, Sharp GC (Hrsg). Mixed connective tissue disease and anti-nuclear antibodies. Amsterdam: Alsevier, 1987: 3340
2. Arnal C, Piette JC, Lone J, Taillan B, Hachulla E, Roudot-Thoraval F, Papo T, Schaeffer A, Bierling P, Godeau B. Treatment of severe immune thrombocytopenia associated with systemic lupus erythematosus: 59 cases. J Rheumatol 2002; 29: 75-83.
3. Comment in: J Rheumatol 2002; 29: 1-2
4. British Committee for Standards in Haematology General Haematology Task Force (BCSH). Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol 2003; 120: 574-596
5. Cooper N, Evangelista ML, Amadori S, Stasi R. Should rituximab be used before or after splenectomy in patients with immune thrombocytopenic purpura? Curr Opin Hematol 2007; 14: 642-646
6. Geddis AE, Balduini CL. Diagnosis of immune thrombocytopenic purpura in children. Curr Opin Hematol 2007; 14: 520-525
7. Habermalz B et al. Laparoscopic splenectomy: the clinical practice guidelines of the European Association for Endoscopic Surgery (EAES). Surg Endosc 2008; 22 (4): 821-848, Epub 2008 Feb 22
8. Hall S, McCormick JLJr , Greipp PR, Michet CJJr , McKenna CH. Splenectomy does not cure the thrombocytopenia of systemic lupus erythematosus. Ann Intern Med 1985; 102: 325-328
9. Hartung A, Seelig HP. Labordiagnostik der systemischen Autoimmunerkrankungen, Teil I: Kollagenosen. Z Rheumatol 2006; 65: 709-724
10. Ismet A, Irfan K, Emin K, AlI EM, Ramazan U, Mustafa B, Onur O. Splenectomy results in patients with idiopathic thrombocytopenic purpura: 10 years of experience in Turgut Ozal Medical Center. Clin Lab Haematol 2004; 26: 211-214
11. Kojouri K, Vesely SK, Terrell DR, George JN. Splenectomy for adult patients with idiopathic thrombocytopeniy purpura: a systematic review to assess long-term platelet count responses, prediction of response and surgical complications. Blood 2004; 104: 2623-2634
12. Kotajima L, Aotsuka S, Sumiya M, Yokohari R, Tojo T, Kasukawa R. Clinical features of patients with juvenile onset mixed connective tissue disease: analysis of data collected in a nation-wide collaborative study in Japan. J Rheumatol 1996; 23: 1088-1099
13. Lechner K, Pabinger-Fasching I. Hämorrhagische Diathesen. In: Gerok W, Huber C, Thomas M, Zeidler H (Hrsg). Die Innere Medizin, 11. Aufl. Schattauer, 2007: 79-100
14. Lindholm C, Brjesson-Asp K, Zendjanchi K, Sundqvist AC, Tarkowski A, Bokarewa M. Longterm Clinical and Immunological Effects of Anti-CD20 Treatment in Patients with Refractory Systemic Lupus Erythematosus. J Rheumatol 2008; 35 (5): 826-833, Epub 2008 Apr 1
15. Penalver FJ, Jimenez-Yuste V, Almagro M et al. Rituximab in the management of chronic immune thrombocytopenic purpura: an effective and safe therapeutic alternative in refractory patients. Ann Hematol 2006; 85: 400-406
16. Ramos-Calsas M, Brito-Pern P, Muoz S, Soto MJ BIOGEAS STUDY Group. A systemic review of the off-label use ob biological therapies in systemic autoimmune diseases. Medicine (Baltimore) 2008; 87: 345-364
17. Schroers R, Dhrsen U. Idiopathische thrombozytopenische Purpura. Dtsch Med Wochenschr 2007; 132: 383-390
18. Thomas L. Labor und Diagnose, 6. Auflage,. 2005
19. Venables PJW. Overlap syndromes. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH (Hrsg). Rheumatology, Vol. 2, 3rd ed. Elsevier, 2003: 15731580.